204 related articles for article (PubMed ID: 35514192)
21. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
22. Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer.
Shey MS; Balfour A; Wilkinson KA; Meintjes G
Innate Immun; 2018 May; 24(4):192-202. PubMed ID: 29631470
[TBL] [Abstract][Full Text] [Related]
23. MAIT cells and MR1-antigen recognition.
Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
[TBL] [Abstract][Full Text] [Related]
24. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection.
Chua WJ; Truscott SM; Eickhoff CS; Blazevic A; Hoft DF; Hansen TH
Infect Immun; 2012 Sep; 80(9):3256-67. PubMed ID: 22778103
[TBL] [Abstract][Full Text] [Related]
25. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.
Zumwalde NA; Haag JD; Gould MN; Gumperz JE
Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917
[TBL] [Abstract][Full Text] [Related]
26. Potential of MAIT cells to modulate asthma.
Shimizu Y; Sugimoto C; Wakao H
Allergol Int; 2024 Jan; 73(1):40-47. PubMed ID: 37567833
[TBL] [Abstract][Full Text] [Related]
27. Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation.
Tastan C; Karhan E; Zhou W; Fleming E; Voigt AY; Yao X; Wang L; Horne M; Placek L; Kozhaya L; Oh J; Unutmaz D
Mucosal Immunol; 2018 Nov; 11(6):1591-1605. PubMed ID: 30115998
[TBL] [Abstract][Full Text] [Related]
28. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
Corbett AJ; Awad W; Wang H; Chen Z
Front Immunol; 2020; 11():1961. PubMed ID: 32973800
[TBL] [Abstract][Full Text] [Related]
29. TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells.
Ussher JE; van Wilgenburg B; Hannaway RF; Ruustal K; Phalora P; Kurioka A; Hansen TH; Willberg CB; Phillips RE; Klenerman P
Eur J Immunol; 2016 Jul; 46(7):1600-14. PubMed ID: 27105778
[TBL] [Abstract][Full Text] [Related]
30. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection.
Meierovics A; Yankelevich WJ; Cowley SC
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):E3119-28. PubMed ID: 23898209
[TBL] [Abstract][Full Text] [Related]
31. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
32. MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation.
Gibbs A; Leeansyah E; Introini A; Paquin-Proulx D; Hasselrot K; Andersson E; Broliden K; Sandberg JK; Tjernlund A
Mucosal Immunol; 2017 Jan; 10(1):35-45. PubMed ID: 27049062
[TBL] [Abstract][Full Text] [Related]
33. IL-33 Enhances IFNγ and TNFα Production by Human MAIT Cells: A New Pro-Th1 Effect of IL-33.
Azzout M; Dietrich C; Machavoine F; Gastineau P; Bottier A; Lezmi G; Leite-de-Moraes M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638950
[TBL] [Abstract][Full Text] [Related]
34. TAK1 is essential for MAIT cell development and the differentiation of MAIT1 and MAIT17.
Krevh R; Wang J; Zuniga B; Toor J; Subedi K; Zhou L; Mi QS
Cell Mol Immunol; 2023 Jul; 20(7):854-856. PubMed ID: 36973488
[No Abstract] [Full Text] [Related]
35. Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells.
Dias J; Hengst J; Parrot T; Leeansyah E; Lunemann S; Malone DFG; Hardtke S; Strauss O; Zimmer CL; Berglin L; Schirdewahn T; Ciesek S; Marquardt N; von Hahn T; Manns MP; Cornberg M; Ljunggren HG; Wedemeyer H; Sandberg JK; Björkström NK
J Hepatol; 2019 Aug; 71(2):301-312. PubMed ID: 31100314
[TBL] [Abstract][Full Text] [Related]
36. Human MAIT-cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity.
Dias J; Sobkowiak MJ; Sandberg JK; Leeansyah E
J Leukoc Biol; 2016 Jul; 100(1):233-40. PubMed ID: 27034405
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of lineage decisions in metabolite-specific T cells.
Legoux F; Gilet J; Procopio E; Echasserieau K; Bernardeau K; Lantz O
Nat Immunol; 2019 Sep; 20(9):1244-1255. PubMed ID: 31431722
[TBL] [Abstract][Full Text] [Related]
38. Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response.
Ruf B; Catania VV; Wabitsch S; Ma C; Diggs LP; Zhang Q; Heinrich B; Subramanyam V; Cui LL; Pouzolles M; Evans CN; Chari R; Sakai S; Oh S; Barry CE; Barber DL; Greten TF
Cancer Immunol Res; 2021 Sep; 9(9):1024-1034. PubMed ID: 34193462
[TBL] [Abstract][Full Text] [Related]
39. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
[TBL] [Abstract][Full Text] [Related]
40. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.
Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM
Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
